Open Access
Med Sci (Paris)
Volume 37, Number 5, Mai 2021
La révolution médicale du dépistage néonatal – Une aventure médicale scientifique et sociétale
Page(s) 468 - 473
Section La révolution médicale du dépistage néonatal – Une aventure médicale scientifique et sociétale
Published online 18 May 2021
  1. Wiedemann A, Oussalah A, Jeannesson E, et al. La phénylcétonurie : de la diététique à la thérapie génique. Med Sci (Paris) 2020; 36 : 725–34. [EDP Sciences] [Google Scholar]
  2. Folling I. The discovery of phenylketonuria. Acta Paediatr 1994 ; 407(suppl): 4–10. [Google Scholar]
  3. Penrose L, Quastel JH. Metabolic studies in phenylketonuria. Biochem J 1937 ; 31 : 266–274. [Google Scholar]
  4. Bickel H. Diagnosis and therapy of galactosemia and phenylketonuria. Monatsschrift Kinderheilkunde 1955 ; 103 : 81–84. [Google Scholar]
  5. Centerwall WR. Phenylketonuria. J Am Med Assoc 1957 ; 165 : 392. [Google Scholar]
  6. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963 ; 32 : 338–343. [PubMed] [Google Scholar]
  7. Woo SL, Lidsky AS, Guttler Fet al. Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria. Nature 1983 ; 306 : 151–155. [PubMed] [Google Scholar]
  8. Danks DM, Cotton RG, Schlesinger P. Letter: Tetrahydrobiopterin treatment of variant form of phenylketonuria. Lancet 1975 ; 2 : 1043. [Google Scholar]
  9. Anikster Y, Haack TB, Vilboux Tet al. Biallelic mutations in DNAJC12 cause hyperphenylalaninemia, dystonia, and intellectual disability. Am J Hum Genet 2017 ; 100 : 257–266. [Google Scholar]
  10. Van Wegberg AMJ, MacDonald A, Ahring Ket al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis 2017 ; 12 : 162. [CrossRef] [PubMed] [Google Scholar]
  11. HAS. Plan National de Diagnostic et de Soins. Phénylcétonurie. 2018. [Google Scholar]
  12. Abadie V, Berthelot J, Feillet Fet al. Neonatal screening and long-term follow-up of phenylketonuria: the French database. Early Hum Dev 2001 ; 65 : 149–158. [CrossRef] [PubMed] [Google Scholar]
  13. Searle B, Mijuskovic MB, Widelock D, Davidow B. A manual fluorometric paper disc method for detecting phenylketonuria. Clin Chem 1967 ; 13 : 621–625. [CrossRef] [PubMed] [Google Scholar]
  14. HAS. 2011. [Google Scholar]
  15. van Spronsen FJ, van Wegberg AM, Ahring Ket al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol 2017 ; 5 : 743–756. [CrossRef] [PubMed] [Google Scholar]
  16. Camp KM, Parisi MA, Acosta PBet al. Phenylketonuria scientific review conference: state of the science and future research needs. Mol Genet Metab 2014 ; 112 : 87–122. [CrossRef] [PubMed] [Google Scholar]
  17. Muntau AC, du Moulin M, Feillet F. Diagnostic and therapeutic recommendations for the treatment of hyperphenylalaninemia in patients 0–4 years of age. Orphanet J Rare Dis 2018 ; 13 : 173. [CrossRef] [PubMed] [Google Scholar]
  18. Blau N, Dhondt JL. Tetrahydrobiopterin deficiency and an international database of patients. Adv Exp Med Biol 1993 ; 338 : 255–261. [CrossRef] [PubMed] [Google Scholar]
  19. CNCDN. 2020. [Google Scholar]
  20. Kaufman S, Berlow S, Summer GKet al. Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria. N Engl J Med 1978 ; 299 : 673–679. [CrossRef] [PubMed] [Google Scholar]
  21. Blau N, Thony B, Spada M, Ponzone A. Tetrahydrobiopterin and inherited hyperphenylalaninemias. Turk J Pediatr 1996 ; 38 : 19–35. [PubMed] [Google Scholar]
  22. Blau N, Barnes I, Dhondt JL. International database of tetrahydrobiopterin deficiencies. J Inherit Metab Dis 1996 ; 19 : 8–14. [CrossRef] [PubMed] [Google Scholar]
  23. Shakespeare L, Downing M, Allen Jet al. Elevated phenylalanine on newborn screening: follow-up testing may reveal undiagnosed galactosaemia. Ann Clin Biochem 2010 ; 47 : 567–569. [CrossRef] [PubMed] [Google Scholar]
  24. Jeannesson-Thivisol E, Feillet F, Chery Cet al. Genotype-phenotype associations in French patients with phenylketonuria and importance of genotype for full assessment of tetrahydrobiopterin responsiveness. Orphanet J Rare Dis 2015 ; 10 : 158. [CrossRef] [PubMed] [Google Scholar]
  25. Seki M, Takizawa T, Suzuki Set al. Adult phenylketonuria presenting with subacute severe neurologic symptoms. J Clin Neurosci 2015 ; 22 : 1361–1363. [CrossRef] [PubMed] [Google Scholar]
  26. Rubin S, Piffer AL, Rougier MBet al. Sight-threatening phenylketonuric encephalopathy in a young adult, reversed by diet. JIMD Reports 2013 ; 10 : 83–85. [CrossRef] [PubMed] [Google Scholar]
  27. Ashe K, Kelso W, Farrand Set al. Psychiatric and cognitive aspects of phenylketonuria: the limitations of diet and promise of new treatments. Front Psychiatry 2019 ; 10 : 561. [CrossRef] [PubMed] [Google Scholar]
  28. Burton BK, Jones KB, Cederbaum Set al. Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria. Mol Genet Metab 2018 ; 125 : 228–234. [CrossRef] [PubMed] [Google Scholar]
  29. Trefz KF, Muntau AC, Kohlscheen KMet al. Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities: a retrospective study of German health insurance claims data. Orphanet J Rare Dis 2019 ; 14 : 181. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.